NASDAQ:HSCS HeartSciences (HSCS) Stock Price, News & Analysis $2.06 -0.02 (-0.96%) Closing price 11/17/2026 04:00 PM EasternExtended Trading$2.24 +0.18 (+8.79%) As of 07:35 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About HeartSciences Stock (NASDAQ:HSCS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get HeartSciences alerts:Sign Up Key Stats Today's Range$2.05▼$2.1950-Day Range$2.06▼$5.2052-Week Range$1.63▼$5.25Volume17,544 shsAverage Volume91,864 shsMarket Capitalization$10.24 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingHold Company Overview HeartSciences develops medical technology intended to help healthcare professionals detect heart conditions using electrocardiograms (ECGs). The company combines ECG testing with software-based analysis to support the assessment of cardiac function. Its MyoVista wavECG device is designed to perform standard ECG testing while also analyzing the heart’s electrical signals for information that may help identify dysfunction, including diastolic dysfunction. The company’s offerings are aimed at clinical settings where ECGs are used to evaluate patients’ heart health. HeartSciences focuses on developing and commercializing these technologies for healthcare providers. Its products are intended to complement existing diagnostic workflows; medical professionals determine how results are interpreted and used in patient care.AI Generated. May Contain Errors. Read More HeartSciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreHSCS MarketRank™: 2.119898639635 of 5 starsHeartSciences scored higher than 42% of companies evaluated by MarketBeat, and ranked 636th out of 859 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingHeartSciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialHeartSciences has a consensus price target of $8.00, representing about 288.3% upside from its current price of $2.06.Amount of Analyst CoverageHeartSciences has only been the subject of 1 research reports in the past 90 days.Read more about HeartSciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for HeartSciences are expected to grow in the coming year, from ($2.99) to ($2.01) per share.Price to Book Value per Share RatioHeartSciences has a P/B Ratio of 29.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about HeartSciences' valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.63% of the float of HeartSciences has been sold short.Short Interest Ratio / Days to CoverHeartSciences has a short interest ratio ("days to cover") of 1.37, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in HeartSciences has recently increased by 96.47%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHeartSciences does not currently pay a dividend.Dividend GrowthHeartSciences does not have a long track record of dividend growth. News and Social Media2.4 / 5News SentimentN/A News SentimentHeartSciences has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for HeartSciences this week, compared to 2 articles on an average week.Search InterestOnly 1 people have searched for HSCS on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, HeartSciences insiders have not sold or bought any company stock.Percentage Held by Insiders4.90% of the stock of HeartSciences is held by insiders.Percentage Held by Institutions17.24% of the stock of HeartSciences is held by institutions.Read more about HeartSciences' insider trading history. Receive HSCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HeartSciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HSCS Stock News HeadlinesFortitude Reports Financial and Operating Results for the Nine Months Ended September 30, 2026November 16 at 7:30 AM | globenewswire.comHeartSciences (NASDAQ:HSCS) Stock Crosses Above Two Hundred Day Moving Average - Should You Sell?November 7, 2026 | americanbankingnews.comEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now he's filed to launch 1,000,000 AI satellites, a move Dylan believes could mean a 100X bigger royalty bill starting December 8th. This free pick names the public company collecting on every unit.November 18 at 1:00 AM | Behind the Markets (Ad)HeartSciences Adds Supplemental Disclosures to Merger Proxy StatementNovember 6, 2026 | tipranks.comHeartSciences Files Definitive Proxy Statement for Proposed Business Combination with Fortitude MiningOctober 21, 2026 | globenewswire.comHeartSciences Wins FDA Clearance For MyoVista WavECG; Fortitude Lines Up $100 Mln Miner DealOctober 6, 2026 | rttnews.comHeartSciences' MyoVista WavECG Device Gets FDA 510(k) ClearanceOctober 6, 2026 | rttnews.comHeartSciences Receives FDA 510(k) Clearance for its MyoVista® wavECGTM DeviceOctober 6, 2026 | globenewswire.comSee More Headlines HSCS Stock Analysis - Frequently Asked Questions How have HSCS shares performed this year? HeartSciences' stock was trading at $3.09 at the beginning of the year. Since then, HSCS stock has decreased by 33.3% and is now trading at $2.06. How were HeartSciences' earnings last quarter? HeartSciences Inc. (NASDAQ:HSCS) released its quarterly earnings data on Monday, September, 14th. The company reported ($0.86) EPS for the quarter, missing the consensus estimate of ($0.72) by $0.14. The business had revenue of $2.10 thousand for the quarter, compared to the consensus estimate of $100 thousand. When did HeartSciences' stock split? HeartSciences shares reverse split on the morning of Friday, May 17th 2024.The 1-100 reverse split was announced on Friday, May 17th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 17th 2024. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. When did HeartSciences IPO? HeartSciences (HSCS) raised $9 million in an initial public offering (IPO) on Wednesday, June 15th 2022. The company issued 1,800,000 shares at $4.50-$5.50 per share. The Benchmark Company served as the underwriter for the IPO. How do I buy shares of HeartSciences? Shares of HSCS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of HeartSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that HeartSciences investors own include Tesla (TSLA), GE Aerospace (GE), Visa (V), SPDR Dow Jones Industrial Average ETF Trust (DIA), American Express (AXP), Bollinger Innovations (BINI) and Cardio Diagnostics (CDIO). Company Calendar Last Earnings9/14/2026Today11/18/2026EGM 202611/19/2026Next Earnings (Estimated)12/21/2026Fiscal Year End4/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 For the last 2 weeks, HSCS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:HSCS CIK1468492 Webheartsciences.com Phone682-237-7781FaxN/AEmployees14Year FoundedN/APrice Target and Rating Average Price Target for HeartSciences$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+288.3%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($3.22) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.14 million Net MarginsN/A Pretax Margin-256,474.97% Return on Equity-816.90% Return on Assets-181.97% Debt Debt-to-Equity RatioN/A Current Ratio0.14 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.07 per share Price / Book29.43Miscellaneous Outstanding Shares4,970,000Free Float4,726,000Market Cap$10.24 million OptionableNot Optionable Beta1.80 The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:HSCS) was last updated on 11/17/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | SponsoredIntel Shares Jumped 177% After Elon Musk's DealElon Musk's April 2026 partnership with Intel sent shares climbing 177% within two months. Jeff Brown, the ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HeartSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HeartSciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.